Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1069-1080 of 1735 results
Page 90 of 145
Key Publications February 14, 2017

HDL infusion for the management of atherosclerosis: current developments and new directions.

Curr Opin Lipidol. 2016;27:592-596

Zheng KH, Stroes ES
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 14, 2017

The future of lipid guidelines.

Curr Opin Lipidol. 2016;27:585-591

Robinson JG
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 13, 2017

Risk prediction: Are we there yet?

Circulation. 2016;134:1441-1443

Jensen JK
Cardiovascular Disease Epidemiology Prevention
Key Publications February 13, 2017

New oral agents for treating dyslipidemia.

Curr Opin Lipidol. 2016;27:579-584

Gryn SE, Hegele RA
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 10, 2017

Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population.

Circulation. 2016;134:1419-1429

Kaasenbrood L, Boekholdt SM, van der Graaf Y, Ray KK, Peters RJ, Kastelein JJ, Amarenco P, LaRosa JC, Cramer MJ, Westerink J, Kappelle LJ, de Borst GJ, Visseren FL
Cardiovascular Disease Epidemiology Prevention
Key Publications February 10, 2017

Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: The China-PAR Project (Prediction for ASCVD Risk in China).

Circulation. 2016;134:1430-1440

Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C, Yu L, Lu F, Wu X, Zhao L, Wu X, Gu D
Cardiovascular Disease Epidemiology Prevention
Key Publications February 8, 2017

A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease.

Am Heart J. 2016;181:92-100

Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, Gibson CM, Ohman EM
Cardiovascular Disease Prevention Thrombosis
Key Publications February 3, 2017

Taxes on sugar-sweetened beverages to reduce overweight and obesity in middle-income countries: A systematic review.

PLoS One. 2016;11:e0163358

Nakhimovsky SS, Feigl AB, Avila C, O'Sullivan G, Macgregor-Skinner E, Spranca M
Nutrition Obesity Prevention
Key Publications January 30, 2017

Comparison of dietary intakes between a large online cohort study (Etude NutriNet-Santé) and a nationally representative cross-sectional study (Etude Nationale Nutrition Santé) in France: Addressing the issue of generalizability in e-epidemiology.

Am J Epidemiol. 2016;184:660-669

Andreeva VA, Deschamps V, Salanave B, Castetbon K, Verdot C, Kesse-Guyot E, Hercberg S
Epidemiology Nutrition Prevention
Key Publications January 23, 2017

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult.

Can J Cardiol. 2016;32:1263-1282

Anderson TJ, Grégoire J, Pearson GJ, Barry AR, Couture P, Dawes M, Francis GA, Genest J Jr, Grover S, Gupta M, Hegele RA, Lau DC, Leiter LA, Lonn E, Mancini GB, McPherson R, Ngui D, Poirier P, Sievenpiper JL, Stone JA, Thanassoulis G, Ward R
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications January 20, 2017

Physical activity/exercise and diabetes: A position statement of the American Diabetes Association.

Diabetes Care. 2016;39:2065-2079

Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, Horton ES, Castorino K, Tate DF
Diabetes Physical Activity/Exercise Prevention
Key Publications January 19, 2017

2016 ESC/EAS guidelines for the management of dyslipidaemias.

Eur Heart J. 2016;37:2999-3058

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW et al.
Cardiovascular Disease Lipids/Lipoproteins Prevention
of 145